Evidence map›Paper›PMID 41029976›Full record

ArticleHuman vaccines & immunotherapeutics2025

The relationship between socio-economic inequity indicators and 4CMenB vaccination rates in infants and adolescents in Spain: An ecological correlation study.

Georgios Nikitas, Laura A Vallejo, Andrew G Allmon, Kieran Brooks, Jennifer Gaultney, Alen Marijam

Abstract read
In one paragraph

Article in Human vaccines & immunotherapeutics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Georgios NikitasMedical Evidence Generation, GSK, Wavre, Belgium.ORCID 0000-0002-2495-9756
Laura A VallejoMarket Access, GSK, Madrid, Spain.
Andrew G AllmonReal-World Evidence, GSK, North Carolina, USA.
Kieran BrooksReal-World Methods and Evidence Generation, IQVIA, London, UK.
Jennifer GaultneyHealth Economics and Health Technology Assessment, IQVIA, London, UK.
Alen MarijamVaccines HEOR and Epidemiology, GSK, Wavre, Belgium.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Invasive meningococcal disease (IMD) is associated with a high mortality rate and can cause severe long-term sequelae. In Spain, the majority of IMD cases are caused by serogroup B. The four-component meningococcal serogroup B vaccine (4CMenB) is included in the Spanish infant National Immunisation Plan (NIP); however, vaccination of other age groups is not yet publicly funded. This analysis aimed to estimate infant and adolescent 4CMenB vaccination rates across Spanish autonomous regions and municipalities and their correlation with income, higher education and unemployment from 2019 to 2022, prior to inclusion of 4CMenB within the Spanish NIP. Correlation between vaccination rates and income per capita, higher education and employment status was assessed across municipalities using Spearman's coefficient. In 2022, infant 4CMenB vaccination rates across autonomous regions were highest in Cantabria (61.87%), across municipalities this was Ciudad Real (72.40%), and were lowest in Melilla (12.20%) across both. Adolescent 4CMenB vaccination rates were highest in Galicia (5.14%) across autonomous regions, and Lugo (6.05%) across municipalities, and lowest in Cantabria (0.09%) across both. A significant and positive correlation was observed between infant 4CMenB vaccination rates and income per capita (

Indexed as

Meningococcal InfectionsMeningococcal VaccinesVaccinationVaccination CoverageAdolescentChildChild, PreschoolFemaleHumansImmunization ProgramsIncomeInfantMaleSocioeconomic FactorsSpain4CMenB vaccineMeningococcal Vaccines4CMenBinequityinvasive meningococcal diseaseNeisseria meningitidissocio-economicSpainvaccines

Identifiers

PMID41029976
PMCPMC12489997

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.